search icon
  • Print
  • ShareThis
  • Text Size

IDSA News Releases

07/19/2016

HCV Guidance Website Updated to Reflect Latest Drug Developments

HCVguidelines.org, a website developed by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) to provide up-to-date guidance on the treatment of hepatitis C (HCV) has updated several sections of the website based on newly available therapies and data.
07/14/2016

Shorter Courses of Antibiotics Safe for Treatment of Patients with Hospital-Acquired, Ventilator-Associated Pneumonia

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) - which account for 20 to 25 percent of hospital-acquired infections - should be treated with shorter courses of antibiotics than they typically are, according to new guidelines released by the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) and published in the journal Clinical Infectious Diseases.
06/30/2016

Early Diagnosis, Effective Therapy Vital for Treatment of Deadly Invasive Aspergillosis

New therapies are improving care, but early diagnosis remains critical in the effective treatment of invasive aspergillosis, a potentially deadly fungal infection, according to new guidelines released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.
04/18/2016

IDSA Names Christopher D. Busky, CAE, as the Society’s New CEO

The Society’s next top staffer brings extensive experience in association management and has a track record for organizational leadership representing healthcare professionals.
04/14/2016

New Antibiotic Stewardship Guidelines Focus on Practical Advice for Implementation

Preauthorization of broad-spectrum antibiotics and prospective review after two or three days of treatment should form the cornerstone of antibiotic stewardship programs to ensure the right drug is prescribed at the right time for the right diagnosis. These are among the numerous recommendations included in new guidelines released by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) and published in the journal Clinical Infectious Diseases.
03/31/2016

Presidential Advisory Council on Combating Antibiotic Resistant Bacteria Report

Recommendations from the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria reflect IDSA input.
02/25/2016

HCV Guidance Website Updated to Reflect Latest Drug Developments

The latest release of the guidance reflects several important developments, including the recent approval of the second single-tablet fixed dose combination regimen (elbasvir/grazoprevir) for the treatment of HCV.

| HIVMA | Contact Us

© Copyright IDSA 2016 Infectious Diseases Society of America

Full Site Mobile Site